Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

NCT02671864 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

7200

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

OTHER: 1: incretin-based therapy
OTHER: 2: other antidiabetic

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]